|
England and Wales
|
001-35573 |
98-1467236
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
263 Tresser Boulevard, Suite 1100
|
|
Laporte Road, Stallingborough
|
|
Stamford, Connecticut 06901
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
| Ordinary shares, par value $0.01 per share |
TROX |
NYSE |
|
Item 2.02.
|
Results of Operations and Financial Condition.
|
|
Item 9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit No.
|
|
Description |
|
Earnings Release, dated April 30, 2025.
|
||
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K. |
|
TRONOX HOLDINGS PLC
|
|||
|
Date: May 1, 2025
|
By:
|
/s/ Jeffrey N. Neuman
|
|
|
Name:
|
Jeffrey N. Neuman
|
||
|
Title:
|
Senior Vice President, General Counsel and Secretary
|
||
| • |
Revenue of $738 million, a 9% increase compared to the prior quarter and a 5% decrease compared to the prior year
|
| • |
Loss from operations of $61 million; Net loss of $111 million including $87 million of restructuring and other charges, primarily non-cash costs associated
with the idling of the Company's Botlek pigment plant as announced in March; adjusted net loss was $24 million (non-GAAP)
|
| • |
GAAP diluted loss per share was $0.70; Adjusted diluted loss per share was $0.15 (non-GAAP)
|
| • |
Adjusted EBITDA of $112 million; Adjusted EBITDA margin of 15.2% (non-GAAP)
|
| • |
Capital expenditures of $110 million in the quarter
|
| • |
Maintaining previous guidance for 2025 Revenue ($3.0-3.4 billion), Adjusted EBITDA ($525-625 million), and free cash flow (greater than $50 million)
|
| • |
Capital expenditures reduced to be less than $365 million in 2025
|
| • |
Actions underway expected to deliver $125-$175 million in sustainable, run-rate cost improvements by end of 2026
|
|
($M unless otherwise noted)
|
Q1 2025
|
Q1 2024
|
Y-o-Y % ∆
|
|
Q4 2024
|
Q-o-Q % ∆
|
|
|||||||||||||
|
Revenue
|
$
|
738
|
$
|
774
|
(5
|
)%
|
$
|
676
|
9
|
%
|
||||||||||
|
TiO2
|
$
|
584
|
$
|
605
|
(3
|
)%
|
$
|
533
|
10
|
%
|
||||||||||
|
Zircon
|
$
|
69
|
$
|
88
|
(22
|
)%
|
$
|
75
|
(8)
|
)%
|
||||||||||
|
Other products
|
$
|
85
|
$
|
81
|
5
|
%
|
$
|
68
|
25
|
%
|
||||||||||
|
(Loss) Income from operations
|
$
|
(61
|
)
|
$
|
41
|
n/m
|
|
$
|
48
|
n/m
|
|
|||||||||
|
Net (Loss) Income attributable to Tronox
|
$
|
(111
|
)
|
$
|
(9
|
)
|
n/m
|
|
$
|
(30
|
)
|
n/m
|
|
|||||||
|
GAAP diluted (loss) earnings per share
|
$
|
(0.70
|
)
|
$
|
(0.06
|
)
|
n/m
|
|
$
|
(0.19
|
)
|
n/m
|
|
|||||||
|
Adjusted diluted (loss) earnings per share
|
$
|
(0.15
|
)
|
$
|
(0.05
|
)
|
n/m
|
|
$
|
0.03
|
n/m
|
|
||||||||
|
Adjusted EBITDA
|
$
|
112
|
$
|
131
|
(15
|
)%
|
$
|
129
|
(13
|
)%
|
||||||||||
|
Adjusted EBITDA Margin %
|
15.2
|
%
|
16.9
|
%
|
(170)bps
|
19.1
|
%
|
(390) bps
|
||||||||||||
|
Free cash flow
|
$
|
(142
|
)
|
$
|
(105
|
)
|
n/m
|
|
$
|
(35
|
)
|
n/m
|
|
|||||||
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
|
|
TiO2
|
(1)%
|
(1)%
|
(1)%
|
12%
|
(2)%
|
0%
|
|
Zircon
|
(15)%
|
(7)%
|
—
|
(6)%
|
(2)%
|
—
|
|
Three Months Ended March 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net sales
|
$
|
738
|
$
|
774
|
||||
|
Cost of goods sold
|
639
|
654
|
||||||
|
Gross profit
|
99
|
120
|
||||||
|
Restructuring and other charges
|
86
|
—
|
||||||
|
Selling, general and administrative expenses
|
74
|
79
|
||||||
|
(Loss) Income from operations
|
(61
|
)
|
41
|
|||||
|
Interest expense
|
(42
|
)
|
(42
|
)
|
||||
|
Interest income
|
2
|
4
|
||||||
|
Other expense, net
|
(5
|
)
|
(1
|
)
|
||||
|
(Loss) Income before income taxes
|
(106
|
)
|
2
|
|||||
|
Income tax provision
|
(5
|
)
|
(11
|
)
|
||||
|
Net loss
|
(111
|
)
|
(9
|
)
|
||||
|
Net (loss) income attributable to noncontrolling interest
|
—
|
—
|
||||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(111
|
)
|
$
|
(9
|
)
|
||
|
Loss per share:
|
||||||||
|
Basic
|
$
|
(0.70
|
)
|
$
|
(0.06
|
)
|
||
|
Diluted
|
$
|
(0.70
|
)
|
$
|
(0.06
|
)
|
||
|
Weighted average shares outstanding, basic (in thousands)
|
158,138
|
157,331
|
||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
158,138
|
157,331
|
||||||
|
Other Operating Data:
|
||||||||
|
Capital expenditures
|
110
|
76
|
||||||
|
Depreciation, depletion and amortization expense
|
71
|
72
|
||||||
|
Three Months Ended March 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(111
|
)
|
$
|
(9
|
)
|
||
|
Restructuring and other charges (a)
|
86
|
—
|
||||||
|
Other (b)
|
1
|
2
|
||||||
|
Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
(24
|
)
|
$
|
(7
|
)
|
||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(0.70
|
)
|
$
|
(0.06
|
)
|
||
|
Restructuring and other charges, per share
|
0.54
|
—
|
||||||
|
Other, per share
|
0.01
|
0.01
|
||||||
|
Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
|
$
|
(0.15
|
)
|
$
|
(0.05
|
)
|
|
|
Weighted average shares outstanding, diluted (in thousands)
|
158,138
|
157,331
|
||||||
|
March 31, 2025
|
December 31, 2024
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
138
|
$
|
151
|
||||
|
Restricted cash
|
—
|
1
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of March 31, 2025 and December 31, 2024, respectively)
|
319
|
266
|
||||||
|
Inventories, net
|
1,605
|
1,551
|
||||||
|
Prepaid and other assets
|
129
|
184
|
||||||
|
Income taxes receivable
|
2
|
2
|
||||||
|
Total current assets
|
2,193
|
2,155
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,922
|
1,927
|
||||||
|
Mineral leaseholds, net
|
614
|
616
|
||||||
|
Intangible assets, net
|
243
|
244
|
||||||
|
Lease right of use assets, net
|
137
|
140
|
||||||
|
Deferred tax assets
|
831
|
830
|
||||||
|
Other long-term assets
|
129
|
126
|
||||||
|
Total assets
|
$
|
6,069
|
$
|
6,038
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
478
|
$
|
499
|
||||
|
Accrued liabilities
|
239
|
247
|
||||||
|
Short-term lease liabilities
|
23
|
24
|
||||||
|
Short-term debt
|
183
|
65
|
||||||
|
Long-term debt due within one year
|
38
|
35
|
||||||
|
Income taxes payable
|
—
|
4
|
||||||
|
Total current liabilities
|
961
|
874
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
2,753
|
2,759
|
||||||
|
Pension and postretirement healthcare benefits
|
86
|
85
|
||||||
|
Asset retirement obligations
|
191
|
172
|
||||||
|
Environmental liabilities
|
41
|
40
|
||||||
|
Long-term lease liabilities
|
106
|
107
|
||||||
|
Deferred tax liabilities
|
181
|
174
|
||||||
|
Other long-term liabilities
|
44
|
36
|
||||||
|
Total liabilities
|
4,363
|
4,247
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 158,462,071 shares issued and outstanding at March 31, 2025 and 157,938,056 shares issued and outstanding at
December 31, 2024
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,089
|
2,084
|
||||||
|
Retained earnings
|
425
|
555
|
||||||
|
Accumulated other comprehensive loss
|
(842
|
)
|
(880
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,674
|
1,761
|
||||||
|
Noncontrolling interest
|
32
|
30
|
||||||
|
Total equity
|
1,706
|
1,791
|
||||||
|
Total liabilities and equity
|
$
|
6,069
|
$
|
6,038
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(111
|
)
|
$
|
(9
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
71
|
72
|
||||||
|
Deferred income taxes
|
4
|
11
|
||||||
|
Share-based compensation expense
|
5
|
6
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
2
|
2
|
||||||
|
Restructuring and other charges
|
86
|
-
|
||||||
|
Other non-cash items affecting net income (loss)
|
12
|
16
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(49
|
)
|
(94
|
)
|
||||
|
(Increase) decrease in inventories, net
|
(35
|
)
|
11
|
|||||
|
Decrease in prepaid and other assets
|
18
|
16
|
||||||
|
Restructuring payments
|
(2
|
)
|
-
|
|||||
|
Decrease in accounts payable and accrued liabilities
|
(22
|
)
|
(49
|
)
|
||||
|
Net changes in income tax payables and receivables
|
(4
|
)
|
(3
|
)
|
||||
|
Changes in other non-current assets and liabilities
|
(7
|
)
|
(8
|
)
|
||||
|
Cash used in operating activities
|
(32
|
)
|
(29
|
)
|
||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(110
|
)
|
(76
|
)
|
||||
|
Loans
|
15
|
-
|
||||||
|
Cash used in investing activities
|
(95
|
)
|
(76
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(6
|
)
|
(6
|
)
|
||||
|
Repayments of long-term debt
|
(6
|
)
|
(5
|
)
|
||||
|
Proceeds from short-term debt
|
121
|
-
|
||||||
|
Dividends paid
|
-
|
(1
|
)
|
|||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
(1
|
)
|
-
|
|||||
|
Cash provided by (used in) financing activities
|
108
|
(12
|
)
|
|||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
5
|
(2
|
)
|
|||||
|
Net decrease in cash and cash equivalents and restricted cash
|
(14
|
)
|
(119
|
)
|
||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
152
|
273
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
138
|
$
|
154
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net loss (U.S. GAAP)
|
$
|
(111
|
)
|
$
|
(9
|
)
|
||
|
Interest expense
|
42
|
42
|
||||||
|
Interest income
|
(2
|
)
|
(4
|
)
|
||||
|
Income tax provision
|
5
|
11
|
||||||
|
Depreciation, depletion and amortization expense
|
71
|
72
|
||||||
|
EBITDA (non-U.S. GAAP)
|
5
|
112
|
||||||
|
Share-based compensation (a)
|
5
|
6
|
||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (b)
|
7
|
7
|
||||||
|
Accounts receivable securitization program (c)
|
4
|
3
|
||||||
|
Foreign currency remeasurement (d)
|
1
|
(2
|
)
|
|||||
|
Restructuring and other charges (e)
|
86
|
—
|
||||||
|
Other items (f)
|
4
|
5
|
||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
112
|
$
|
131
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
Net sales
|
$
|
738
|
$
|
774
|
||||
|
Net loss (U.S. GAAP)
|
$
|
(111
|
)
|
$
|
(9
|
)
|
||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(15.0
|
)%
|
(1.2
|
)%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
15.2
|
%
|
16.9
|
%
|
||||
|
March 31, 2025
|
December 31, 2024
|
|||||||
|
Long-term debt, net
|
$
|
2,753
|
$
|
2,759
|
||||
|
Short-term debt
|
183
|
65
|
||||||
|
Long-term debt due within one year
|
38
|
35
|
||||||
|
(Less) Cash and cash equivalents
|
(138
|
)
|
(151
|
)
|
||||
|
Net debt
|
$
|
2,836
|
$
|
2,708
|
||||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$
|
545
|
$
|
564
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
5.2
|
x
|
4.8
|
x
|
||||
|
Three Months Ended March 31, 2025
|
||||
|
Cash used in operating activities
|
$
|
(32
|
)
|
|
|
Capital expenditures
|
(110
|
)
|
||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(142
|
)
|
|
|
|
Three Months Ended
|
Trailing Twelve
Month Adjusted
EBITDA
|
||||||||||||||||||
|
June 30, 2024
|
September 30, 2024
|
|
December 31, 2024
|
March 31, 2025
|
||||||||||||||||
|
Net income (loss) (U.S. GAAP)
|
$
|
10
|
$
|
(25
|
)
|
$
|
(30
|
)
|
$
|
(111
|
)
|
$
|
(156
|
)
|
||||||
|
Interest expense
|
42
|
42
|
41
|
42
|
167
|
|||||||||||||||
|
Interest income
|
(2
|
)
|
(3
|
)
|
(1
|
)
|
(2
|
)
|
(8
|
)
|
||||||||||
|
Income tax provision
|
45
|
26
|
45
|
5
|
121
|
|||||||||||||||
|
Depreciation, depletion
and amortization expense
|
72
|
70
|
71
|
71
|
284
|
|||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
167
|
110
|
126
|
5
|
408
|
|||||||||||||||
|
Share-based compensation (a)
|
4
|
7
|
4
|
5
|
20
|
|||||||||||||||
|
Foreign currency remeasurement (b)
|
4
|
8
|
(11
|
)
|
1
|
2
|
||||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c)
|
7
|
8
|
1
|
7
|
23
|
|||||||||||||||
|
Accounts receivable securitization program (d)
|
4
|
4
|
4
|
4
|
16
|
|||||||||||||||
|
Sale of royalty interest (e)
|
(28
|
)
|
—
|
—
|
—
|
(28
|
)
|
|||||||||||||
|
Restructuring and other charges (f)
|
—
|
—
|
—
|
86
|
86
|
|||||||||||||||
|
Loss on extinguishment of debt (g)
|
—
|
3
|
—
|
—
|
3
|
|||||||||||||||
|
Other items (h)
|
3
|
3
|
5
|
4
|
15
|
|||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
161
|
$
|
143
|
$
|
129
|
$
|
112
|
$
|
545
|
||||||||||